Ensign Peak Advisors, Inc Denali Therapeutics Inc. Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 346,304 shares of DNLI stock, worth $8.37 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

346,304

Previous 346,304 -0.0%

Holding current value

$8.37 Million

Previous $8.04 Million 25.44%

% of portfolio

0.02%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$15.83 - $23.35 $34,715 - $51,206	-2,193 Reduced 0.63%	346,304 $7.11 Million
Q3 2023 Nov 13, 2023	BUY	$20.63 - $30.17 $4.13 Million - $6.03 Million	200,000 Added 134.68%	348,497 $7.19 Million
Q2 2023 Aug 14, 2023	BUY	$23.37 - $32.96 $92,311 - $130,192	3,950 Added 2.73%	148,497 $4.38 Million
Q1 2023 May 15, 2023	BUY	$21.91 - $32.67 $43,820 - $65,340	2,000 Added 1.4%	144,547 $3.33 Million
Q4 2022 Feb 13, 2023	BUY	$26.28 - $33.92 $522,972 - $675,008	19,900 Added 16.23%	142,547 $3.96 Million
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $960,240 - $1.42 Million	36,975 Added 43.16%	122,647 $3.76 Million
Q2 2022 Aug 12, 2022	SELL	$20.88 - $35.19 $394,715 - $665,231	-18,904 Reduced 18.08%	85,672 $2.52 Million
Q1 2022 May 16, 2022	BUY	$29.0 - $47.27 $3,480 - $5,672	120 Added 0.11%	104,576 $3.37 Million
Q4 2021 Feb 11, 2022	BUY	$42.59 - $55.02 $1.62 Million - $2.1 Million	38,108 Added 57.44%	104,456 $4.66 Million
Q3 2021 Nov 12, 2021	BUY	$48.48 - $78.23 $1.18 Million - $1.91 Million	24,406 Added 58.19%	66,348 $3.35 Million
Q2 2021 Aug 13, 2021	BUY	$50.3 - $78.44 $15,090 - $23,532	300 Added 0.72%	41,942 $3.29 Million
Q1 2021 May 12, 2021	SELL	$53.8 - $81.53 $875,864 - $1.33 Million	-16,280 Reduced 28.11%	41,642 $2.38 Million
Q4 2020 Feb 12, 2021	BUY	$36.89 - $93.56 $7,414 - $18,805	201 Added 0.35%	57,922 $4.85 Million
Q3 2020 Nov 12, 2020	BUY	$23.13 - $38.84 $9,575 - $16,079	414 Added 0.72%	57,721 $2.07 Million
Q2 2020 Aug 12, 2020	SELL	$16.01 - $28.82 $1.09 Million - $1.96 Million	-67,842 Reduced 54.21%	57,307 $1.39 Million
Q1 2020 May 11, 2020	BUY	$14.2 - $27.98 $1.66 Million - $3.28 Million	117,173 Added 1469.07%	125,149 $2.19 Million
Q4 2019 Feb 14, 2020	BUY	$14.4 - $19.99 $114,854 - $159,440	7,976 New	7,976 $139,000

Others Institutions Holding DNLI

# of Institutions

228

Shares Held

120M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.24B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Denali Therapeutics Inc. Transaction History